EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Bimetallic Nanoreactor Activates cGAS‐STING Pathway via mtDNA Release for Cancer Metalloimmunotherapy

Xin Wang Mo, Nguyen Thi Nguyen, LiLi Guo, Ngoc Man Phan, Hyunsu Shin, Tae‐il Kim, Yu Seok Youn, Jaeyun Kim

Advanced Functional Materials · 2026-03 · 36 (26)

DOI: 10.1002/adfm.202518279 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Functional Materials, online erschienen am 20.11.2025. Verfasst von Xin Wang Mo und 7 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, South Korea.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Manganese‐based materials are promising candidates for supporting cyclic dinucleotides for activating the cyclic GMP‐AMP synthase–stimulator of interferon genes (cGAS‐STING) pathway, which is crucial for inducing immune responses against cancer. However, their limited capacity to independently stimulate the STING pathway restricts their clinical potential. To overcome this limitation, a bimetallic nanoreactor (MCC) is developed to activate the cGAS‐STING pathway for metalloimmunotherapy. Upon cellular uptake, MCC induces mitochondrial and cellular damage by generating toxic hydroxyl radicals and causing calcium ions overload, subsequently leading to the release of mitochondrial DNA (mtDNA) and tumor‐associated antigens. The released mtDNA, in combination with manganese ions, effectively activates the cGAS‐STING pathway, improving the antigen‐presenting capacity of antigen‐presenting cells (APCs) and stimulating adaptive immune responses. In vivo experiments demonstrate that MCC substantially inhibits tumor growth in B16‐OVA and 4T1 tumor models, while promoting the infiltration of T lymphocytes and APCs into the tumor, accompanied by increased immune cell levels in the tumor‐draining lymph node and spleen. Moreover, MCC effectively reduces lung metastasis of melanoma in combination with anti‐programmed death 1. These results emphasize MCC as a non‐nucleotide, bimetallic manganese‐calcium STING nanoagonist for cancer metalloimmunotherapy, providing a promising paradigm for treating primary as well as metastatic tumors.

Förderung

  • Ministry of Science and ICT, South Korea

Zitieren

APA

Mo, X. W., Nguyen, N. T., Guo, L., Phan, N. M., Shin, H., Kim, T., Youn, Y. S., & Kim, J. (2026). Bimetallic Nanoreactor Activates cGAS‐STING Pathway via mtDNA Release for Cancer Metalloimmunotherapy. Advanced Functional Materials, 36(26). https://doi.org/10.1002/adfm.202518279

Vancouver

Mo XW, Nguyen NT, Guo L, Phan NM, Shin H, Kim T, et al. Bimetallic Nanoreactor Activates cGAS‐STING Pathway via mtDNA Release for Cancer Metalloimmunotherapy. Advanced Functional Materials. 2026;36(26). doi:10.1002/adfm.202518279

BibTeX
@article{Mo2026,
  author = {Mo, Xin Wang and Nguyen, Nguyen Thi and Guo, LiLi and Phan, Ngoc Man and Shin, Hyunsu and Kim, Tae‐il and Youn, Yu Seok and Kim, Jaeyun},
  title = {Bimetallic Nanoreactor Activates cGAS‐STING Pathway via mtDNA Release for Cancer Metalloimmunotherapy},
  journal = {Advanced Functional Materials},
  year = {2026},
  volume = {36},
  number = {26},
  doi = {10.1002/adfm.202518279}
}
Kostenlos starten →